Sponsored by: Fujifilm

MRI: Page 347

Toshiba's RSNA highlights include new 320-row CT scanner
By Brian Casey
CHICAGO - A new flagship 320-detector-row CT scanner, a price drop for its 1.5-telsa MRI scanner, and new technologies in ultrasound and wireless digital x-ray are among the highlights in the RSNA 2012 booth of Toshiba America Medical Systems.
November 25, 2012
2012 11 26 10 57 19 335 Toshiba Aquilion One Vision Ct 02 Thumb
PET/MRI tops DWI-MRI for head/neck lymph node metastases
By Wayne Forrest
CHICAGO - PET/MRI outperformed diffusion-weighted MRI (DWI-MRI) for detecting lymph node metastases in the staging of head and neck cancer patients, according to a study presented on Sunday at the RSNA annual meeting.
November 24, 2012
Hitachi extends oval-bore MRI to 3 tesla with Trillium Oval
By Brian Casey
At the 2011 RSNA meeting, Hitachi Medical Systems America raised eyebrows with the launch of Echelon Oval, a 1.5-tesla MRI scanner with an oval-shaped magnet. This year, Hitachi extends the oval concept to 3 tesla with Trillium Oval, a work-in-progress scanner not yet for sale in the U.S.
November 24, 2012
2012 11 26 11 22 20 599 Hitachi Oval Echelon1 Thumb
German ministry to show country's innovation at RSNA
By AuntMinnie.com staff writers
The German Federal Ministry of Education and Research will sponsor an exhibit at the 2012 RSNA meeting stressing that imaging innovations begun by Wilhelm Röntgen in the 19th century continue in Germany in the 21st century with clinically relevant technologies such as breast CT and PET/MRI.
November 18, 2012
Toshiba offers environmental monitoring system
By AuntMinnie.com staff writers
Toshiba America Medical Systems announced it has launched e-Watch, an environmental monitoring system for imaging suites.
November 18, 2012
Esaote introduces G-scan Brio MRI
By AuntMinnie.com staff writers
Ultrasound vendor Esaote has introduced G-Scan Brio, a second-generation, weight-bearing MRI scanner designed specifically to perform musculoskeletal MRI examinations.
November 18, 2012
Fonar logs flat Q1 results
By AuntMinnie.com staff writers
MRI firm Fonar's financial results were flat in the first quarter of 2013 compared to the same quarter last year, but the firm maintained its recent profitability streak.
November 15, 2012
Road to RSNA 2012: MRI Preview
By Wayne Forrest
At this year's RSNA conference, look for MRI to garner increasing attention as a viable modality in clinical applications where radiation exposure is a concern. In addition, radiologists are using MRI to discover previously hidden secrets in the brain for afflictions such as Alzheimer's disease, cognitive disorders, multiple sclerosis, and stroke.
November 14, 2012
Road to RSNA 2012: MRI Preview
Study shows MRE's benefits for pediatric Crohn's disease patients
By Wayne Forrest
Wednesday, November 28 | 3:30 p.m.-3:40 p.m. | SSM17-04 | Room S102ABMR enterography (MRE) achieves high lesion detectability in pediatric patients with Crohn's disease, researchers from South Korea will report in this scientific session.
November 14, 2012
DWI-MRI proves beneficial for peritoneal metastasis detection
By Wayne Forrest
Wednesday, November 28 | 11:50 a.m.-12:00 p.m. | SSK13-09 | Room S505ABDiffusion-weighted MRI (DWI-MRI) enhances the diagnostic performance of conventional MRI in peritoneal metastasis detection and is comparable to FDG-PET/CT in this clinical application, according to researchers from Hong Kong.
November 14, 2012
MRI reveals possible complications after ACL reconstruction
By Wayne Forrest
Wednesday, November 28 | 11:50 a.m.-12:00 p.m. | SSK10-09 | Room E451AMR images can provide indications of graft complications in patients following anterior cruciate ligament (ACL) reconstruction, according to this study from Egypt.
November 14, 2012
Multiparametric MRI, MR-guided biopsy top TRUS in prostate cancer
By Wayne Forrest
Wednesday, November 28 | 11:40 a.m.-11:50 a.m. | SSK05-08 | Room E353CIn this Wednesday presentation, Dutch researchers will report how repeat 3-tesla multiparametric MRI and MR-guided biopsy outperformed transrectal ultrasound (TRUS) biopsy in upgrading and upstaging patient risk restratification in a prostate cancer study at 12 months of follow-up.
November 14, 2012
Previous Page
Page 347 of 628
Next Page